Completed
Rituximab in IgG4-RD: A Phase 1-2 Trial
NCT01584388
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +24 more
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying Lymphadenopathy. Study availability and eligibility vary by location and protocol.
NCT01584388
Not specified
NCT01916421
NCT00886847
NCT01526486
NCT02360306
NCT00605657
NCT01384357
NCT01130402
NCT00065390
NCT00013689